Skip to content
10-K

Annual Report

BIOSCIENCE HEALTH INNOVATIONS INC. BHIC

0001185185-24-000327

← back to feed
Filed
Mar 29, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Mar 28, 2024 41.6M sh
Operating Cash Flow FY 2023 · Dec 31, 2022 −$182.78K
Cash And Equivalents FY 2023 · Dec 31, 2022 $11.57K
Total Liabilities FY 2023 · Dec 31, 2022 $48.79K
Current Assets FY 2023 · Dec 31, 2022 $31.61K
Total Assets FY 2023 · Dec 31, 2022 $31.61K
Sga Expense FY 2023 · Dec 31, 2022 $151.32K
Net Income FY 2023 · Dec 31, 2022 −$170.45K
Operating Income FY 2023 · Dec 31, 2022 −$170.45K
Gross Profit FY 2023 · Dec 31, 2022 $59.64K
Cost Of Revenue FY 2023 · Dec 31, 2022 $9.7K
Revenue FY 2023 · Dec 31, 2022 $69.34K
Stockholders Equity FY 2023 · Dec 31, 2021 −$1.01K